SC-43
- Product Name
- SC-43
- CAS No.
- 1400989-25-4
- Chemical Name
- SC-43
- Synonyms
- SC-43;1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(3-(4-cyanophenoxy)phenyl)urea;Urea, N-[4-chloro-3-(trifluoromethyl)phenyl]-N'-[3-(4-cyanophenoxy)phenyl]-;antiproliferative,Inhibitor,SC-43,SHP-1,PTPN6,Phosphatase,Apoptosis,caspase-3,SC 43,anti-fibrotic,p-STAT3,anticancer,orally,SC43,PARP,STAT,inhibit
- CBNumber
- CB94801426
- Molecular Formula
- C21H13ClF3N3O2
- Formula Weight
- 431.8
- MOL File
- 1400989-25-4.mol
SC-43 Property
- Boiling point:
- 462.0±45.0 °C(Predicted)
- Density
- 1.46±0.1 g/cm3(Predicted)
- storage temp.
- Store at -20°C
- solubility
- DMSO: 250 mg/mL (578.97 mM)
- form
- A solid
- pka
- 12.92±0.70(Predicted)
- color
- White to off-white
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Warning
- Hazard statements
-
H302Harmful if swallowed
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
- Precautionary statements
-
P264Wash hands thoroughly after handling.
P264Wash skin thouroughly after handling.
P270Do not eat, drink or smoke when using this product.
P280Wear protective gloves/protective clothing/eye protection/face protection.
P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.
P302+P352IF ON SKIN: wash with plenty of soap and water.
P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.
P321Specific treatment (see … on this label).
P330Rinse mouth.
P332+P313IF SKIN irritation occurs: Get medical advice/attention.
P362Take off contaminated clothing and wash before reuse.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- CS-0132863
- Product name
- SC-43
- Purity
- 98.61%
- Packaging
- 5mg
- Price
- $250
- Updated
- 2021/12/16
- Product number
- CS-0132863
- Product name
- SC-43
- Purity
- 98.61%
- Packaging
- 10mg
- Price
- $350
- Updated
- 2021/12/16
- Product number
- CS-0132863
- Product name
- SC-43
- Purity
- 98.61%
- Packaging
- 25mg
- Price
- $650
- Updated
- 2021/12/16
- Product number
- A300602
- Product name
- SC-43
- Purity
- 98+%
- Packaging
- 250mg
- Price
- $610
- Updated
- 2021/12/16
- Product number
- A300602
- Product name
- SC-43
- Purity
- 98+%
- Packaging
- 100mg
- Price
- $310
- Updated
- 2021/12/16
SC-43 Chemical Properties,Usage,Production
Biological Activity
SC-43 is a derivative of sorafenib, an agonist of Src-homology protein tyrosine phosphatase-1 (SHP-1/PTPN6), which reduces liver fibrosis. SC-43 can reduce p-STAT3 and induce apoptosis, and has antitumor activity.
in vitro
SC-43 (0-10 μM; 24-72 hours; HuCCT-1, KKU-100, and CGCCA cells) treatment reveals the anti-proliferative effects in cholangiocarcinoma (CCA) cell lines in a dose-dependent manner after treating 24, 48 and 72 hours respectively.
Its treatment shows increased sub-G1 cells and G2-M arrest, indicating SC-43 induced differential apoptotic effects in these cell lines.
Its (0-10 μM; 24 hours; HuCCT-1, KKU-100, and CGCCA cells) treatment demonstrates significant increase in cleaved caspase-3 and PARP level.
Its activates SH2 domain-containing phosphatase 1 (SHP-1) activity, leading to p-STAT3 and downstream cyclin B1 and Cdc2 downregulation. Its augments SHP-1 activity by direct binding to N-SH2 and relief of its autoinhibition.
Cell Cycle Analysis
Cell Line: | HuCCT-1, KKU-100, and CGCCA cells |
Concentration: | 0 μM, 1 μM, 2.5 μM, 5 μM, 10 μM |
Incubation Time: | 24 hours |
Result: | Showed increased sub-G1 cells and G2-M arrest. |
Western Blot Analysis
Cell Line: | HuCCT-1, KKU-100, and CGCCA cells |
Concentration: | 0 μM, 1 μM, 2.5 μM, 5 μM, 10 μM |
Incubation Time: | 24 hours |
Result: | Demonstrated significant increase in cleaved caspase-3 and PARP level. |
in vivo
SC-43 (10-30 mg/kg; oral gavage; daily; for 23 days; male NCr athymic nude mice) treatment exhibits xenograft tumor growth inhibition, p-STAT3 reduction and SHP-1 activity elevation.
Animal Model: | Male NCr athymic nude mice (5-7 weeks of age) injected with HuCCT-1 cells |
Dosage: | 10 mg/kg or 30 mg/kg |
Administration: | Oral gavage; daily; for 23 days |
Result: | Exhibited xenograft tumor growth inhibition, p-STAT3 reduction and SHP-1 activity elevation. |
target
Target | Value |
SHP-1 () | |
STAT3 () |
SC-43 Preparation Products And Raw materials
Raw materials
Preparation Products
SC-43 Suppliers
- Tel
- +1-781-999-5354 +1-00000000000
- marketing@targetmol.com
- Country
- United States
- ProdList
- 32165
- Advantage
- 58
- Tel
- +1-+1(833)-552-7181
- sales@aladdinsci.com
- Country
- United States
- ProdList
- 57505
- Advantage
- 58
- Tel
- support@targetmol.com
- Country
- United States
- ProdList
- 38632
- Advantage
- 58
- Tel
- --
- Fax
- --
- cayman@caymanchem.com
- Country
- United States
- ProdList
- 6213
- Advantage
- 81
- Tel
- --
- Fax
- --
- sales@medchemexpress.com
- Country
- United States
- ProdList
- 6398
- Advantage
- 58